RCEL peer analysis
Avita Medical (RCEL) against its competitors: price, today's move, 1-year return and market value side by side.
RCEL and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| APYX Apyx Medical | $2.59 | -0.38% | -19.06% | $109.10M |
| HYPR Hyperfine | $0.75 | 8.36% | -27.86% | – |
| LUCD Lucid Diagnostics | $0.39 | -11.62% | -64.56% | – |
| NSPR InspireMD | $0.78 | 18.71% | -63.25% | $36.58M |
| OVID Ovid Therapeutics | $2.54 | -7.30% | 90.98% | $535.12M |
| STTK Shattuck Labs | $4.59 | -10.87% | 137.82% | – |
| VANI Vivani Medical | $1.07 | 1.90% | -28.90% | – |
| XTNT Xtant Medical | $0.30 | 6.47% | -63.52% | $41.53M |
| RCEL Avita Medical | $15.36 | -5.88% | 324.31% | $511.05M |
- RCEL's peers: APYX (Apyx Medical), HYPR (Hyperfine), LUCD (Lucid Diagnostics), NSPR (InspireMD), OVID (Ovid Therapeutics), STTK (Shattuck Labs), VANI (Vivani Medical), XTNT (Xtant Medical).
Updated 2026-11-06 11:42 UTC